Decibel Therapeutics
Executivos
Veja o organograma con seus 16 executivos principais
Biografias mais buscadas da Decibel Therapeutics
- Laurence Reid, Chief Executive Officer and Director
- Alison Finger, Director
- Kevin McLaughlin, Director
Criar um alerta
para seguir os movimentos de executivos da Decibel Therapeutics.
Biotecnologia
Decibel Therapeutics possui 2.282 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Endeavor BioMedicines acaba de anunciar uma arrecadação de fundos de 132 milhões de dólares. (publicado em 25 de abril de 2024).
- Metsera acaba de anunciar uma arrecadação de fundos de 290 milhões de dólares. (publicado em 23 de abril de 2024).
- Histogen has filed for bankruptcy protection (publicado em 19 de abril de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Decibel Therapeutics
- Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy | Decibel Therapeutics, Inc.
- Decibel Therapeutics Topline Results/Interim Analysis: Phase1b Study of DB-020 in Patients Treated with Cisplatin Chemotherapy
- Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference | Decibel Therapeutics, Inc.
- Decibel Therapeutics to Present at the H.C. Wainwright Global Investment Conference | Decibel Therapeutics, Inc.
- Decibel Therapeutics Reports First Quarter 2022 Financial Results and Corporate Update | Decibel Therapeutics, Inc.
- Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting | Decibel Therapeutics, Inc.
- Decibel Therapeutics to Participate in Upcoming Investor Conferences | Decibel Therapeutics, Inc.
- Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update | Decibel Therapeutics, Inc.
- Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference | Decibel Therapeutics, Inc.
- Decibel Therapeutics Reports on Continued Progress of Lead Gene Therapy Product Candidate DB-OTO and Presents Promising Preclinical Data Supporting Importance of Cell-Selective Transgene Expression Across Gene Therapy Pipeline | Decibel Therapeutics, Inc.
- View more press releases Close
Redes sociais sobre Decibel Therapeutics
- Decibel Therapeutics na Wikipedia, Google News e Yahoo Finance
- Decibel Therapeutics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Laurence Reid 
Ligue para a Decibel Therapeutics em +1 617...
